Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Cysteamine hydrochloride

EU orphan designation number: EU/3/08/578   
Active ingredient: Cysteamine hydrochloride
Indication: Treatment of cystinosis
Sponsor: Orphan Europe S.A.R.L.
Immeuble Le Wilson, 70 avenue du Général de Gaulle, F-92 800 Puteaux, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/11/2008 Centralised Orphan - Designation EMEA/OD/036/08 (2008)6855 of 07/11/2008